BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1241 related articles for article (PubMed ID: 21251164)

  • 21. Evolutionary conserved N-terminal domain of Nrf2 is essential for the Keap1-mediated degradation of the protein by proteasome.
    Katoh Y; Iida K; Kang MI; Kobayashi A; Mizukami M; Tong KI; McMahon M; Hayes JD; Itoh K; Yamamoto M
    Arch Biochem Biophys; 2005 Jan; 433(2):342-50. PubMed ID: 15581590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular cross-talk between the NRF2/KEAP1 signaling pathway, autophagy, and apoptosis.
    Stępkowski TM; Kruszewski MK
    Free Radic Biol Med; 2011 May; 50(9):1186-95. PubMed ID: 21295136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Action of Nrf2 and Keap1 in ARE-mediated NQO1 expression by quercetin.
    Tanigawa S; Fujii M; Hou DX
    Free Radic Biol Med; 2007 Jun; 42(11):1690-703. PubMed ID: 17462537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of the Nrf2/ARE pathway via S-alkylation of cysteine 151 in the chemopreventive agent-sensor Keap1 protein by falcarindiol, a conjugated diacetylene compound.
    Ohnuma T; Nakayama S; Anan E; Nishiyama T; Ogura K; Hiratsuka A
    Toxicol Appl Pharmacol; 2010 Apr; 244(1):27-36. PubMed ID: 20026152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer.
    Singh A; Misra V; Thimmulappa RK; Lee H; Ames S; Hoque MO; Herman JG; Baylin SB; Sidransky D; Gabrielson E; Brock MV; Biswal S
    PLoS Med; 2006 Oct; 3(10):e420. PubMed ID: 17020408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer.
    Hayes JD; McMahon M
    Trends Biochem Sci; 2009 Apr; 34(4):176-88. PubMed ID: 19321346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cul3-mediated Nrf2 ubiquitination and antioxidant response element (ARE) activation are dependent on the partial molar volume at position 151 of Keap1.
    Eggler AL; Small E; Hannink M; Mesecar AD
    Biochem J; 2009 Jul; 422(1):171-80. PubMed ID: 19489739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.
    Shibata T; Kokubu A; Gotoh M; Ojima H; Ohta T; Yamamoto M; Hirohashi S
    Gastroenterology; 2008 Oct; 135(4):1358-1368, 1368.e1-4. PubMed ID: 18692501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The keap1-nrf2 cellular defense pathway: mechanisms of regulation and role in protection against drug-induced toxicity.
    Copple IM; Goldring CE; Kitteringham NR; Park BK
    Handb Exp Pharmacol; 2010; (196):233-66. PubMed ID: 20020265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CAND1-mediated substrate adaptor recycling is required for efficient repression of Nrf2 by Keap1.
    Lo SC; Hannink M
    Mol Cell Biol; 2006 Feb; 26(4):1235-44. PubMed ID: 16449638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity.
    Nioi P; Nguyen T
    Biochem Biophys Res Commun; 2007 Nov; 362(4):816-21. PubMed ID: 17822677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Control of oxidative stress by the Keap1-Nrf2 pathway.
    Stewart JD; Hengstler JG; Bolt HM
    Arch Toxicol; 2011 Apr; 85(4):239. PubMed ID: 21431330
    [No Abstract]   [Full Text] [Related]  

  • 33. Diffusion dynamics of the Keap1-Cullin3 interaction in single live cells.
    Baird L; Dinkova-Kostova AT
    Biochem Biophys Res Commun; 2013 Mar; 433(1):58-65. PubMed ID: 23454126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress.
    Zhang DD; Hannink M
    Mol Cell Biol; 2003 Nov; 23(22):8137-51. PubMed ID: 14585973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of Nrf2 transcription factor in cellular response to oxidative stress].
    Florczyk U; Łoboda A; Stachurska A; Józkowicz A; Dulak J
    Postepy Biochem; 2010; 56(2):147-55. PubMed ID: 20873109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear factor p65 interacts with Keap1 to repress the Nrf2-ARE pathway.
    Yu M; Li H; Liu Q; Liu F; Tang L; Li C; Yuan Y; Zhan Y; Xu W; Li W; Chen H; Ge C; Wang J; Yang X
    Cell Signal; 2011 May; 23(5):883-92. PubMed ID: 21262351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of NRF2 by nitrosative agents and H2O2 involves KEAP1 disulfide formation.
    Fourquet S; Guerois R; Biard D; Toledano MB
    J Biol Chem; 2010 Mar; 285(11):8463-71. PubMed ID: 20061377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cysteine-based regulation of the CUL3 adaptor protein Keap1.
    Sekhar KR; Rachakonda G; Freeman ML
    Toxicol Appl Pharmacol; 2010 Apr; 244(1):21-6. PubMed ID: 19560482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling.
    Lo SC; Li X; Henzl MT; Beamer LJ; Hannink M
    EMBO J; 2006 Aug; 25(15):3605-17. PubMed ID: 16888629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different electrostatic potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response.
    Tong KI; Padmanabhan B; Kobayashi A; Shang C; Hirotsu Y; Yokoyama S; Yamamoto M
    Mol Cell Biol; 2007 Nov; 27(21):7511-21. PubMed ID: 17785452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 63.